Clinical trial
A Phase II Trial of Bevacizumab in Patients With Relapsed or Refractory Multiple Myeloma
NCT00482495 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Bevacizumab in Patients With Relapsed or Refractory Multiple Myeloma
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- November 30, 2009
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma and plasma cell neoplasm